Accessibility Menu
 
Nascent Biotech logo

Nascent Biotech

(OTC) NBIO

Current Price$0.00
Market Cap$51,700
Since IPO (2014)-100%
5 Year-100%
1 Year-93%
1 Month-40%

Nascent Biotech Financials at a Glance

Market Cap

$51,700

Revenue (TTM)

$3.38

Net Income (TTM)

$1.35M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-4.77 (Low)

Price

$0.00

Volume

35,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.13

NBIO News

No articles available.

NBIO: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Nascent Biotech

Industry

Biotechnology

CEO

Sean Carrick

Headquarters

Vero Beach, FL 32960, US

NBIO Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

9%

Return on Assets

-4%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$51.70K

Shares Outstanding

172.20M

Volume

35.00K

Short Interest

0.00%

Avg. Volume

9.22K

Financials (TTM)

Gross Profit

$320.00K

Operating Income

$2.23M

EBITDA

$527.43K

Operating Cash Flow

$1.19M

Capital Expenditure

$4.00

Free Cash Flow

$1.19M

Cash & ST Invst.

$372.12K

Total Debt

$122.50K

Nascent Biotech Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$51.70K

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

$252.00K

+69.6%

EBITDA

$251.00K

+64.3%

Quarterly Fundamentals

Name
Q2 2025YOY CHG

Net Cash

$57.18K

-108.2%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$59.00K

-80.7%

Return on Assets

-3.78%

N/A

Return on Invested Capital

8.69%

N/A

Free Cash Flow

$324.73K

-99.6%

Operating Cash Flow

$324.73K

-99.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
RLBDReal Brands, Inc.
$0.00+0.00%
PZOOPazoo, Inc.
$0.00+0.00%
VIVXFAvivagen Inc.
$0.00+0.00%
RGRXRegeneRx Biopharmaceuticals, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
RITMRithm Capital
$8.77-0.03%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%
INFYInfosys
$13.12+0.01%

Questions About NBIO

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.